期刊文献+

肿瘤相关巨噬细胞在非肌层浸润性膀胱癌表达的临床意义 被引量:1

Clinical value of tumor-associated macrophages in non-muscle-invasive bladder cancer
原文传递
导出
摘要 目的:探讨肿瘤相关巨噬细胞(TAMs)在非肌层浸润性膀胱癌(NMIBC)表达情况及其临床意义。方法:收集147例NMIBC临床病例资料,运用免疫组织化学染色检测CD163+TAMs在癌组织表达密度,组间比较采用χ2检验,使用Kaplan-Meier法进行生存分析,并用Cox回归多因素模型对患者预后进行分析。结果:在单因素分析中,CD163+TAMs在癌间质低密度和中密度表达复发率分别为11.1%和12.4%,差异无统计学意义(P>0.05);将二者合并,与高密度(37.5%)复发率比较,差异有统计学意义(P<0.05)。进一步分层分析在吸烟、肿瘤多发、肿瘤直径<3cm、肿瘤分级G1和G2及肿瘤分期Ta的患者中,CD163+TAMs表达低中密度和高密度复发率比较,差异有统计学意义(P<0.05);而在性别、年龄、非吸烟、肿瘤单发、肿瘤直径≥3cm、肿瘤分级G3及肿瘤分期T1的患者中,CD163+TAMs表达低中密度和高密度复发率比较,差异无统计学意义(P>0.05)。结论:肿瘤间质中CD163+TAMs可以作为NMIBC临床预后的潜在指标。 Objective:To investigate expression of tumor-associated macrophages in non-muscle-invasive bladder cancer (NMIBC) and it's clinical value.Method:The clinical data were collected from 147 cases of NMIBC.The density of CD163-labeled TAMs (CD163+TAMs) in cancer tissues and adjacent tissues were detected by immunohistochemical staining.The difference between the two groups was analyzed byχ2 test and survival analysis was performed using the Kaplan-Meier method.Cox regression multivariate model was used to analyze the prognosis of the patients.Result:The recurrence rates of CD163+TAMs in low density and medium density were 11.1% and 12.4% (P〈0.05) by univariate analysis,the difference showed no statistical significance.The recurrence rate was statistically significant (P〈0.05) while mild degree combined with moderate degree compared with the interstitial high (37.5%).In the further stratified analysis of recurrence rate,the degree of mildness and high of CD163+TAMs showed statistical difference (P〈0.05) of smoking,multiple tumors,tumor diameter less than3.0cm,tumor grade for G1 and G2 and tumor stage for Tapatients.On the contrary,the above phenomena did not occur in gender,age,non-smoking,single tumor,diameter greater than 3.0cm,grade G3 and stage T1 patients.Conclusion:CD163+TAMs in tumor stroma can be used as a potential prognostic indicator for NMIBC.
作者 宋进 张志强 耿浩 李骏 祝金波 于德新 SONG Jin;ZHANG Zhiqiang;GENG Hao;LI Jun;ZHU Jinbo;YU Dexin(Department of Urology,Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China)
出处 《临床泌尿外科杂志》 2018年第6期458-463,共6页 Journal of Clinical Urology
基金 安徽高校自然科学研究项目(编号KJ2018A0205)
关键词 肿瘤相关巨噬细胞 非肌层浸润性膀胱癌 临床意义 tumor-associated macrophages non-muscle invasive bladder cancer clinical value
  • 相关文献

参考文献4

二级参考文献41

  • 1Qian BZ, Pollard JW. Macrophage diversity enhances tumor progres- sion and metastasis [ J ]. Cell, 2010,141 ( 1 ) : 39 -51.
  • 2Tang X. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer [ J ]. Cancer Lett, 2013,332 (1):3-10.
  • 3Sylvester 1LI, van der Meijden AP, Oosterlinck W, et al. Predicting re- currence and progression in individual patients with stage Ta T1 blad- der cancer using EORTC risk tables:a combined analysis of 2596 pa- tients from seven EORTC trials [ J ]. Eur Uro1,2006,49 ( 3 ) :466465.
  • 4Ali-E1-Dein B, Sooriakumaran P,Trinh QD, et al. Construction of pre- dictive models for recurrence and progression in > 1000 patients with non-muscle-invasive bladder cancer (NMIBC) from a single centre [J]. BJU Int,2013,111 (8) :E331-E341.
  • 5Sauter G, Algaba F, Amin M, et al. Tumour of urina- ry system: nonqnvasive urothelial EM3// Eble J N, Sauter G, Epstein J I, et al. WHO Classifiction of Tumour of urinary system and male genital organs. Ly- on: IARCC Press, 2004: 116-119.
  • 6Sobin L H, Gospodariwicz M K, Wittekind C. TNM classification of malignant tumors[M]. 7th ed. Ox-ford: Wiley-Blackwell, 2009: 262-265.
  • 7Piergentili R, Carradori S, Gulia C, et al. Bladder cancer: innovative approaches beyond the diagnosis[-J:. Curr Med Chem, 2014, 21(20)= 2219-2236.
  • 8Soukup V, Dugkovd J, Pegl M, et al. The prognostic value of T1 bladder cancer substaging: a single institu tion retrospective study:J:. Urol Int, 2014, 92 (2): 150-156.
  • 9Canter D J, Revenig L M, Smith Z L, et al. Re-exami- nation of the natural history of high-grade T1 bladder cancer using a large contemporary cohortEJ:. Int Braz J Urol, 2014, 40(2): 172-178.
  • 10Liss M, Osann K, Ornstein D. Positive surgical mar gins during robotic radical prostatectomy: a contempo- rary analysis of risk factors[J]. BJU Int, 2008, 102 (5): 603-608.

共引文献37

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部